ValenTx (Carpenteria, CA) a development-stage medical device company focused on minimally invasive approaches for the treatment of morbid obesity, closed a $20.3M Series B financing. Participants include SV Life Sciences, Covidien Ventures, Sapient Capital, EDF Ventures, Kaiser Permanente Ventures, Affinity Capital and TGap Ventures.

Barosense (Redwood City, CA) a clinical-stage medical device company focused on minimally invasive trans-oral endoscopic restrictive implant system to treat obesity, closed a $27M Series D financing. Participants include Pappas Ventures, Delphi Ventures, Frazier Healthcare Ventures, Invesco Private Capital, RWI Ventures, Synergy Life Science Partners and Wharton Ventures.

GI Dynamics (Watertown, MA) a clinical-stage medical device company developing noninvasive approaches to treat obesity, type 2 diabetes and related metabolic diseases GI, closed a $15 Series C financing bring the total round to $45M. Participants include Advanced Technology Ventures, Cutlass Capital, Domain Associates, Johnson & Johnson Development, Polaris Venture Partners and Seedling Enterprises.

ReShape Medical (San Clemente, CA) a development-stage medical device manufacturer of a non-surgical product for the treatment of obesity, closed a $20M Series B financing. Participants include U.S. Venture Partners, New Leaf Venture Partners and SV Life Sciences.

Baronova (Goleta, CA) developer of medical devices for the treatment of obesity, closed a $7.5M Series B financing. Participants include Allergan, Arboretum Ventures, Highland Capital Partners and Onset Ventures.